Synthetic Biologics, Inc. (7) | Uncategorized (3)
- DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED (Filed With SEC on March 4, 2021)
- Description of Securities (Filed With SEC on February 20, 2020)
- Clinical Trial Agreement between Washington University School of Medicine in St. Louis and Synthetic Biologics, Inc. dated August 7, 2019 (Filed With SEC on August 8, 2019)
